During the XIX International AIDS Conference, which was held July 22–27, 2012, in Washington, DC, NIDA Director Nora D. Volkow, M.D., joined other National Institutes of Health (NIH) leaders in presenting advances and challenges in AIDS research. Dr.
The NIDA International Program supported the participation of scientists from Argentina, Peru, and South Africa at the 2nd International HIV Treatment as Prevention Workshop, which was held April 22–25, 2012, in Vancouver, Canada. The meeting was organized by Julio S.G. Montaner, M.D., University of British Columbia, and featured a keynote address by U.S. Global AIDS Coordinator Ambassador Eric Goosby about the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) perspective on treatment as prevention.
The NIDA Avant-Garde Award Program for HIV/AIDS Research is now open to international scientists. This award is designed to support individual scientists of exceptional creativity who propose cutting-edge—and possibly transformative—approaches to major challenges in biomedical and behavioral research on HIV/AIDS that are relevant to drug abuse. The award is intended to support high-impact research that will open new areas of HIV/AIDS research and/or lead to new avenues for treatment and prevention of HIV/AIDS among drug abusers.
Late last year, five new research teams began work to address HIV/AIDS and drug use in areas where it is already at epidemic proportions or where it is quickly emerging to become one if efforts are not made to halt or reverse the current momentum. The research projects are the result of NIDA grants designed to stimulate collaborative research among foreign investigators from the same geographic regions to address regional issues on the intersection of HIV/AIDS and drug use in international settings.